Jefferies Maintains Buy on Edwards Lifesciences, Raises Price Target to $107
Portfolio Pulse from Benzinga Newsdesk
Jefferies analyst Matthew Taylor maintains a Buy rating on Edwards Lifesciences (NYSE:EW) and raises the price target from $103 to $107.
July 25, 2023 | 4:21 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Jefferies analyst Matthew Taylor maintains a Buy rating on Edwards Lifesciences and raises the price target from $103 to $107.
The news of Jefferies maintaining a Buy rating and raising the price target for Edwards Lifesciences is likely to have a positive impact on the company's stock. Investors often follow analyst recommendations and price targets, which can influence stock prices.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100